Abstract OBJECTIVES: This study tested the hypothesis that remote perconditioning offers effective and synergistic cardioprotection to terminal warm blood cardioplegia for prompt ventricular recovery after prolonged cardioplegic arrest in an in vivo piglet model.
INTRODUCTION
Remote perconditioning (rPerC) was first proposed in 2007 by Schmidt et al. [1] as a novel endogenous cardioprotective strategy in which brief, repeated ischaemic stimuli are applied to a distant organ (i.e. a limb) during ischaemia of a target organ (myocardium) prior to the onset of reperfusion. In an in vivo porcine model of 40 min of left anterior descending coronary artery occlusion with 120 min of reperfusion, Schmidt et al. [1] demonstrated that rPerC at the time of established myocardial ischaemia reduced the extent of infarction and associated with improved functional indexes by a K ATP channel-dependent mechanism; they proposed the term 'remote perconditioning'. The protocols for remote ischaemic pre-and postconditioning have been extensively investigated, and numerous studies of in vivo coronary ligation models in various species have revealed a universal protective effect against myocardial infarction [2] . More recently, this strategy has been adopted in humans and clinical studies of percutaneous coronary intervention [3] and cardiac surgery [4] . The benefits of rPerC on troponin release have been demonstrated.
However, its effects on myocardial function other than the antinecrotic effect have not been evaluated in previous investigations [2] [3] [4] . Therefore, we argue that the real clinical role of rPerC during open-heart surgery can be confirmed practically if its benefit on global myocardial function is demonstrated in conjunction with the clinically available myocardial protection strategies. Terminal warm blood cardioplegia (TWBCP), first advocated by Buckberg et al. [5] , is a well-established representative procedure for reperfusion injury to resuscitate damaged myocardium during ischaemia and constitutes an essential part of 'integrated myocardial protection' in clinical practice [6] . The current study tested the hypothesis that rPerC in the lower limb offers effective and synergistic cardioprotection with TWBCP for prompt ventricular recovery after prolonged cardioplegic arrest in an in vivo piglet model, especially relevant to paediatric patients.
MATERIALS AND METHODS
All experimental animals received humane care in compliance with the 'Guide for the Care and Use of Laboratory Animals' (National Institutes of Health Publication No. 85-23, revised 1996). The present study was approved by the Animal Care and Use Committee of the Jikei University of Medicine.
Experimental preparation
White-Mandrake-Durex female piglets (weight, 16-19 kg; age, 7-9 weeks) were initially anaesthetized with intramuscular medetomidine hydrochloride and butorphanol tartrate. After tracheostomy, each piglet was ventilated with a volume-cycled respirator using oxygen, air and 1-1.5% isoflurane. After midline sternotomy, a conductance catheter (Millar Instruments, Houston, TX, USA) was inserted into the left ventricle (LV) from the apex to measure cardiac volume and pressure. A snare was passed around the inferior vena cava for preparing reduction of preload to change pressure-volume (P-V) loops. The Mills Pressure-Volume Loop System (Millar Instruments, Houston, TX, USA) and Power Lab (AD Instruments, Sydney, Australia) were used to collect data on a series of LV P-V correlation data during vena cava occlusion. After heparinization (0.3 ml/kg), a 12-Fr arterial cannula was positioned in the aortic arch via the right carotid artery and a 24-Fr cannula was placed in the right atrium. The cardiopulmonary bypass (CPB) circuit was primed with heparin sodium, hydroxyethylated starch, D-mannitol, sodium bicarbonate, 20% albumin and methylprednisolone (30 mg/kg) without homologous blood transfusion. The CPB system consisted of an extracorporeal membrane oxygenator (HPO-06RHF-CP; Senko Medical Instrument Mfg, Tokyo, Japan) and extracorporeal pump (HAS-P100; Senko Medical Instrument Mfg). An 8-Fr cannula was advanced into the left atrium for venting the left side of the heart during cardiac arrest. An aortic root cannula with side branches for administration of the cardioplegic solution, pressure monitoring and venting was inserted into the aortic root.
Experimental protocol
Following animal preparation and instrumentation, baseline control measurements of all parameters were obtained. CPB was initiated at a flow rate of approximately 2.2 l/min/m 2 , representing 70 ml/kg/min. Arterial blood pressure was maintained at 60 mmHg, with a pH of 7.35 to 7.45, oxygen tension greater than 150 mmHg and carbon dioxide tension of 35-45 mmHg, under systemic normothermia. An aortic cross-clamp was applied approximately 10 min after starting CPB, and cardioplegic arrest was initiated with 400 ml of St Thomas Hospital II solution (Miotector; Mochida, Tokyo, Japan) infused within 3 min at an aortic root pressure of 50-80 mmHg. Temperature of cardioplegia was 8 C. Topical cooling with ice shavings was performed. The heart was subjected to 120 min of global ischaemia without additional cardioplegia. No inotropic or vasoactive drugs were used. The heart was kept in an empty beating state for 30 min after reperfusion, then the piglet was weaned from CPB and observed for 30 min up to 60 min of total reperfusion period. After post ischaemic cardiac function measurements and blood sampling, the piglets were euthanized under deep anaesthesia.
Experimental groups
Piglets were divided into the following groups on the basis of the method of reperfusion (Fig. 1) .
Group I (control): This group underwent uncontrolled reperfusion. In 6 piglets, the cross-clamp was simply removed, and the heart was reperfused at a perfusion pressure of 50-70 mmHg. No cardioprotective technique was applied with reperfusion.
Group II (rPerC): In 6 piglets, an rPerC technique in the lower limb was performed 40 min before reperfusion. Remote perconditioning consisted of 4 cycles of 5 min of lower limb ischaemia using a digital tourniquet. Cuff pressure was set at 250 mmHg during ischaemia. This protocol for rPerC was determined based on previous studies that compared different perconditioning algorithms [7] or tested different allocation timings [1, 4, 7, 8] .
Group III (TWBCP): In 6 piglets, after 120 min of ischaemia, TWBCP (37 C) was performed 5 min prior to the onset of aortic unclamping, at a dose of 10 ml/kg/min for 5 min and an aortic pressure of 30-40 mmHg. For TWBCP, the St Thomas Hospital Solution II was used, with added aspartic acid, bicarbonate and a citrate-phosphate-dextrose solution to make a hypocalcaemic (0.54 ± 0.03 mmol/l), alkalotic (pH: 7.361 ± 0.092) and substrateenriched blood cardioplegia solution (4:1; blood/crystalloid, haemoglobin level, 7.8 ± 2.2 g/dl). Aspartic acid was added to replenish the substrate depleted during ischaemia.
Group IV (rPerC ± TWBCP): Both rPerC and TWBCP techniques were performed as described above.
Evaluations
Myocardial performance. A series of LV P-V loops was obtained by the Mills Pressure-Volume Loop System and Power Lab through transient occlusion of the inferior vena cava by tightening and releasing a tape snare during an 8-second period of apnoea at baseline before the onset of CPB and after 60 min of reperfusion. LV performance was assessed by P-V loop analysis with LabChart7 software (AD Instruments) and functional recovery of values after reperfusion were assessed as percentages of the respective baseline values.
Left ventricular contractility: LV contractility was assessed from the slope of the end-systolic P-V relationship by linear regression analysis, end-systolic elastance and preload recruitable stroke work as the slope of the linear regression between end-diastolic volume and LV stroke work.
Diastolic compliance: The slope of the end-diastolic P-V relationship (EDPVR) was calculated from a series of P-V loops through transient occlusion of the inferior vena cava, and LV compliance was assessed as the inverse of EDPVR.
Biochemical parameters: plasma troponin T. Arterial blood samples were acquired just after the initiation of CPB, and after 1, 10, 30 and 60 min of reperfusion or unclamping. Biochemical myocardial injury was determined by measuring plasma troponin T concentrations using the electrochemiluminescent immunoassay method.
Statistical analysis
The sample size was calculated based on the inverse of EDPVR. A total sample size of 24 animals was required to detect a mean increase of recovery of 25% with the rPerC treatment, assuming a common standard deviation of 20% and a power of 80% with a 2-sided significance level of 0.05. We also assumed that the effect of the combination treatment when compared with TWBCP alone is the same as that of the single treatment with rPerC compared with the control. As functional assessments were not feasible due to haemodynamic instability after the termination of CPB in one experiment in Group II, those data were imputed as the half value of the worst data among all the piglets to reflect a low value. Data are summarized as mean value and standard deviation or 95% confidence intervals (CIs) for continuous variables.
The primary analysis was conducted using the 2-sample t-test to compare the rPerC treatments versus non-rPerC treatments. For the sensitivity analyses, we performed analysis of variance (ANOVA) with rPerC (with/without) and TWBCP (with/without) as factors. If rPerC was indicated as a significant factor, we performed ANOVA with the same 2 factors and their interaction. As some data were imputed, the normality of the residual distribution was examined using the normal quantile-quantile plot to confirm the assumption of the parametric analyses. All statistical analyses were 2-sided, and a P-value <0.05 was considered statistically significant. Analyses were performed with SAS 9.4 (SAS Institute Inc., Cary, NC, USA).
RESULTS
Of the total 29 piglets, 5 piglets used in this study did not tolerate surgical preparation or the technical difficulties in measuring correct cardiac function. The remaining 24 piglets were allocated to 4 groups for data analysis. Baseline data were analysed by performing one-way ANOVA. No significant difference existed at baseline absolute values among the groups (Table 1) .
Left ventricular systolic function: end-systolic elastance TWBCP with or without rPerC showed a significant effect on systolic functional recovery, percentage recovery in end-systolic elastance (mean difference, 61% recovery; 95% CI, 38.6-84.1, P < 0.0001, ANOVA) (Fig. 2) . No statistically significant difference in end-systolic elastance was found between the group treated with and that treated without rPerC (mean difference, 10.1% recovery; 95% CI, -25.0 to 45.1, P = 0.56, t-test). RPerC in conjunction with TWBCP showed a modest effect in comparison with the effect of TWBCP alone (122.8% recovery vs 99.9% recovery).
Left ventricular systolic function: preload recruitable stroke work Significant effects on systolic functional recovery as a percentage recovery of preload recruitable stroke work were found (mean difference, 20.9% recovery; 95% CI, 0.4-54.3, P = 0.047, ANOVA) (Fig. 3) . No statistically significant difference in preload recruitable stroke work was found between the group treated with rPerC and that treated without rPerC (mean difference, 20.9% recovery; 95% CI, -8.0 to 49.8, P = 0.15, t-test). rPerC in conjunction with TWBCP showed a modest effect in comparison with the effect of TWBCP alone (94.3% recovery vs 70.3% recovery).
Left ventricular diastolic function: inverse of enddiastolic pressure-volume relationship rPerC showed a significant effect on diastolic compliance recovery, percentage recovery of the inverse of EDPVR (P = 0.036, t-test and; P = 0.035, ANOVA, respectively) (Fig. 4) . The mean difference in percentage recovery between the group treated with rPerC and that treated without rPerC was 21.6% [95% CI, 1.6-41.6 (t-test) and 1.7-41.2 (ANOVA), respectively]. rPerC showed a marked percentage recovery in the inverse of EDPVR both with and without TWBCP (67.5% recovery vs 65.2% recovery).
For examining the normality of the residual distribution, the t-test and the ANOVA were robust. Next, we performed ANOVA with the same 2 factors and their interaction; however, the interaction was not significant. The Wilcoxon rank-sum test was performed as a sensitivity analysis, and similar results were obtained for both systolic and diastolic function.
Biochemical parameters
The profile of plasma troponin T levels over time is shown in Fig.  5 . We performed a repeated-measures ANOVA, where with/without rPerC, with/without TWBCP are between-subject effects and time, and the all interaction of time and the between-subject effects are within subject effects. Troponin T showed a clear significant increase over time. There was no significant difference in upward trend with or without rPerC or TWBCP.
DISCUSSION
The present study demonstrates that rPerC, induced by intermittent limb ischaemia administered in the late phase of established myocardial ischaemia prior to the onset of reperfusion, exerts synergistic cardioprotective effects with TWBCP on LV systolic and diastolic functional recovery after global ischaemia/reperfusion in an in vivo piglet model of prolonged single-dose cardioplegic arrest simulating paediatric open-heart surgery. This study represents a novel experimental investigation testing the benefit of rPerC after global myocardial ischaemia in an in vivo study using CPB, in contrast to previous studies [1, 2] . We confirmed the clinical benefits of this novel reperfusion strategy, as a rescue or troubleshooting strategy in situations where ischaemic intervals are unexpectedly prolonged or myocardial protection is technically inadequate.
Remote versus local ischaemic conditioning
We recently demonstrated that ischaemic postconditioning promotes LV systolic and diastolic function recovery after prolonged cardioplegic arrest [9] . Local ischaemic postconditioning to the heart is a simple and reproducible procedure but may have the disadvantage of inducing additional myocardial ischaemia. In practical terms, the invasive technique of repetitive manipulation of the aortic cross-clamp may increase the risk of aortic dissection and crucial embolism in clinical cardiac surgery. Given these concerns about the application of ischaemic postconditioning, a novel, alternative approach to reduce ischaemia reperfusion injury of a target organ (i.e. myocardium) is 'remote ischaemic conditioning' induced by brief repetitive ischaemia and reperfusion in distant organs, as first reported in 2000 by Oxman et al. [10] . Remote conditioning stimuli in various organs have been experimentally evaluated, including occlusion of the renal artery [11] , carotid artery [12] , femoral artery [13] and the opposite left coronary artery (intra-organ remote conditioning) [12] , in addition to the upper or lower limbs as the most non-invasive method [2, 10] .
Mode of remote ischaemia conditioning: the rationale of remote perconditioning and its applications
Application of remote ischaemic conditioning can be made before target organ (i.e. myocardial) ischaemia (rPerC) or at the onset of reperfusion (remote postconditioning) and can also even be applied during target organ ischaemia (rPerC). Among the different settings (timings), rPerC, first proposed in 2007 by Schmidt et al. [1] offers even more beneficial features from a practical perspective, since an adequate set-up interval must be provided to provoke a protective pathway or mechanism within the target organ from the remote ischaemic stimulus at the onset of reperfusion injury. Basalay et al. [13] compared the efficacy of remote conditioning at different timings (i.e. remote pre-, per-, and postconditioning) in a rat coronary occlusion model and demonstrated comparable reductions in infarct size between protocols but not with delayed application of postconditioning. Since the first report in 2007, experimental studies on the protective effects of rPerC against infarct size have been reported in various species [2] . To date, the majority of clinical applications of rPerC have been randomized clinical trials in myocardial infarction patients who underwent primary percutaneous coronary intervention or thrombolysis [2, 3, 14] . Transient upper or lower limb ischaemia using simple blood pressure cuffs is a simple non-invasive stimulus with important potential clinical applications and an attractive costbenefit ratio. Application of rPerC has recently been translated to cardiac surgery. Li et al. [4] applied either remote preconditioning (rIPC) or rPerC by cuff occlusion of the lower limb in adult patients undergoing valve replacement. Although peak plasma troponin I levels and the incidence of ventricular fibrillation in the rPerC group were lower compared with either control or rIPC group, beneficial effects on myocardial function recovery and haemodynamic status have not been established. To date, no additional data are available regarding the influence of rPerC on myocardial function recovery particularly concerning the clinical protocol of myocardial protection. The benefits demonstrated in the present experimental study cannot be reproducible in clinical trials with a standard protection protocol. Nevertheless, we think that this combination strategy with TWBCP and rPerC deserves consideration as a viable option for rescue or troubleshooting strategy, if rPerC is proved as a safe intervention in a standard clinical setting of cardioplegia.
Optimal algorithms and timing of remote perconditioning
The most important factors influencing the outcomes of perconditioning are assumed to be the timing of treatment and algorithms (length of cycles). In contrast to local postconditioning, in which optimal algorithms are largely species dependent [9] , an almost universal protocol has been successfully applied for rPerC to provide infarct reduction among different species [2] . Xin et al. [7] compared different perconditioning algorithms in an experimental study and demonstrated that only 3-4 cycles of 5-min ischaemic-reperfusion (I-R) resulted in reduced infarct size, whereas no cardioprotection was provided by 1-2 cycles of 10-min I-R or 4 cycles of 1-to 3-min I-R. Several other studies, including the present analysis (4 cycles of 5 min each I-R), have confirmed these findings [2] . Among different allocation timings (i.e. early, late or continuous) [1, 4, 7, 8] , latephase timing is the most widely used method, because the influence of mediators induced by remote conditioning can reach the myocardium only after unclamping of the aorta. The highest concentration of transportable mediators can be achieved by this procedure.
Based on the information available in literature, we applied rPerC (4 cycles of 5 min) using lower limb compression during the last phase of 120 min of ischaemia from 40 min prior to the onset of reperfusion (aortic unclamping) to obtain maximum benefit. In order to trigger the mechanism linking distant and target organs, an adequate stimulus from the remote organ is essential. In our pilot study, remote stimuli induced by occlusion of the femoral artery or abdominal aorta did not provide any benefits, unlike tourniquet compression of the lower limb; such results may imply the importance of the intensity of remote-organ ischaemia over the extent of the ischaemic area in provoking a conditioning pathway.
Functional and biochemical outcome
The key finding in the present study was that rPerC in addition to TWBCP reduced both systolic and diastolic LV dysfunction after prolonged cardioplegic arrest. In a coronary ligation model, Schmidt et al. [1] demonstrated that rPerC preserves global systolic and diastolic function and showed that the protective effects of rPerC were abolished by the administration of glibenclamide a K ATP channel inhibitor. TWBCP, which was advocated by Buckberg et al. [5, 6] is a standard and well-known representative procedure for reperfusion injury and constitutes an essential part of 'integrated myocardial protection' in clinical practice [6] . The rationale of using TWBCP is the active resuscitation of the ischaemically damaged, substrate-depleted heart by maximizing the kinetics of repair and minimizing oxygen demands by maintaining arrest [5, 15] . Although TWBCP has been shown to accelerate myocardial metabolic recovery characterized by a more rapid shift to aerobic metabolism and better preservation of tissue ATP concentration [15] , it may be insufficient to protect against inevitable reperfusion injury after prolonged ischaemia with this modality alone. The present study did not confirm rPerC effects on myocardial biochemical injury.
We speculate that the short time span for measuring troponin release might be one of the reasons for the absence of biochemical benefits in any of the tested interventions, in addition to the small number of experiments and the large variability of data. This also explains the inconsistent results between the clinical report on open-heart surgery and the present result regarding enzyme release.
Clinical implications
It might be argued that prolonged single-dose crystalloid cardioplegic arrest may not seem clinically relevant, as multi-dose blood or crystalloid cardioplegia is widely used as a routine practice in most cases. The present experimental model (120 min of single-dose crystalloid cardioplegic arrest) is intended to simulate critical clinical conditions of incomplete or inappropriate myocardial protection in which ischaemic intervals are unexpectedly prolonged or myocardial protection is inadequate, owing to structural or practical difficulties in optimal cardioplegic delivery. Furthermore, recent trends for the prevalence of a certain type of single-dose cardioplegia (i.e. del Nido cardioplegia) performed for practical reasons in adults (i.e. minimally invasive cardiac surgery) and paediatric cardiac surgery may increase the risk of incomplete myocardial protection from prolonged ischaemia, especially during normothermic CPB without topical cooling.
The modality examined in the present study may be useful as a rescue or troubleshooting strategy under these conditions, where TWBCP alone may not be very helpful. This easy-to-use, low-risk and promising protective strategy can be applied in every elective and unscheduled high-risk situation, whenever a greater danger of developing reperfusion injury exists. In addition to cardiac surgery, organ transplantations during donor surgery might be a good candidate indication for use of this promising method. In the present study, the clinical role of rPerC during extended cardiac surgery (i.e. 4-6 h) with standard myocardial protection using multi-dose blood cardioplegia has not been established due to the technical and practical difficulties in the experimental setting of prolonged use of CPB per se (>4 h). These limitations regarding the nature of the acute animal experiment would necessitate further investigation in a well-designed randomized clinical trial in cardiac surgery.
Limitations
The limited study size is a shortcoming of the present investigation that may cause potential statistical type II error. The very short time span of blood sampling for troponin release is another shortcoming of the present protocol. Longer observation is essential to assess the real net troponin release, because it is usually reported to peak 8 h after acute myocardial infarction. Nevertheless, in the present study, the reason for restricting the reperfusion period to only 60 min is an inevitable situation of post bypass pathophysiology induced by I-R or CPB per se in in vivo animal experiments with CPB. Prolonged ischaemia frequently precluded sustained observation sufficiently long after the termination of CPB. Furthermore, the main objective of the present study was to elucidate the functional benefits of the new intervention in the surgical arena in terms of contributing to prompt left ventricular function recovery, especially in a paediatric surgery rather than effects on enzyme release. Histopathological examination of cardiac specimens was not included in this study and should be considered in future investigations. To elucidate the specific mechanism of rPerC, pharmacological manipulation, as reported by Schmidt and colleagues [1] , who tested whether glibenclamide would block the K ATP channel mechanism, might be of interest and useful for future investigation.
CONCLUSION
rPerC offers promising synergistic cardioprotection in combination with TWBCP, implicating potential clinical benefit by contributing to prompt LV systolic and diastolic function recovery, especially myocardial dysfunction induced by prolonged cardioplegic arrest during paediatric open-heart surgery. Since no distinct adverse effects on the myocardium have been demonstrated in this intervention, unlike local ischaemic conditioning, rPerC can be safely applied as a supplemental reperfusion strategy to the standard clinical blood cardioplegia strategy in addition to enhance post-bypass myocardial function recovery contributing to reductions in postoperative morbidity.
